ALS stem cell trial begins at UM Health System with first 2 patients receiving … – EurekAlert (press release)
| EurekAlert (press release) The Phase II trial is approved by the U.S. Food and Drug Administration and funded by Neuralstem, Inc., the Maryland-based company whose stem-cell product the trial is testing. It seeks to study any effect that injected stem cells might have on motor … University Of Michigan Health System Treats Its First Patients In Neuralstem’s …PR Newswire (press release) Neuralstem, Inc. (CUR): Neuralstem rises after announcing start of stem cell trialSeeking Alpha |
